Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Torrent Pharmaceuticals has informed that India Ratings and Research has affirmed the credit rating of the Company’s existing banking facilities, issuer rating and Non-Convertible Debentures (NCDs); and assigned the credit rating for the proposed NCDs of the Company. The ratings have been affirmed/assigned at IND AA+ (Stable).
The above information is a part of company’s filings submitted to BSE.
